Kiora Pharmaceuticals target price cut to $7 from $12
KPRX•Maxim Group cut its target price for Kiora Pharmaceuticals to $7 from $12.
Related News

IHS Holding, MTN extend merger deadline to December 17, 2026
IHS•

National Health Investors cuts target price to $65 from $68
NHI•

Odysight.AI reports financial results for nine months ended September 30, 2026
ODYS•

Aramark Q4 revenue slightly misses estimates; $1 billion buyback announced
ARMK•

Sally Beauty Holdings joins closing bell ceremony to mark 20th listing anniversary
SBH•